1. Three steps to cancer: how phosphorylation of tubulin, tubulin tyrosine ligase and P-glycoprotein may generate and sustain cancer

   • Haitham T. Idriss

   Review 29 April 2004 Pages: 101 - 104

   

2. Population pharmacokinetics of cisplatin in adult cancer patients

   • Felix E. de Jongh
   • James M. Gallo
   • Alex Sparreboom

   Original Article 30 April 2004 Pages: 105 - 112

   

3. In vitro assessment of nucleoside analogs in multiple myeloma

   • Nancy L. Krett
   • Mary Ayres
   • Varsha Gandhi

   Original Article 04 May 2004 Pages: 113 - 121

   

4. Induction of spermidine/spermine N ¹-acetyltransferase in breast cancer tissues treated with the polyamine analogue N ¹,N ¹¹-diethylnorspermine

   • Edward Gabrielson
   • Ellen Tully
   • Robert A. Casero Jr

   Original Article 08 May 2004 Pages: 122 - 126

   

5. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates

   • Stacey L. Berg
   • Alexander Aleksic
   • Susan M. Blaney

   Original Article 18 May 2004 Pages: 127 - 130

   

6. In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein

   • N. Harry Hendrikse
   • Folkert Kuipers
   • Elisabeth G. E. de Vries

   Original Article 30 April 2004 Pages: 131 - 138

   

7. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells

   • Zsuzsanna Horvath
   • Thomas Höchtl
   • Tarik Tihan

   Original Article 04 May 2004 Pages: 139 - 145

   

8. Late-onset delayed excretion of methotrexate

   • Jennifer L. Pauley
   • John Carl Panetta
   • Ching-Hon Pui

   Original Article 18 May 2004 Pages: 146 - 152

   

9. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide

   • Jaime Cárcel-Trullols
   • Francisca Torres-Molina
   • José Esteban Peris

   Original article 27 April 2004 Pages: 153 - 160

   

10. Atypical protein-kinase Cζ, but neither conventional Ca²⁺-dependent protein-kinase C isoenzymes nor Ca²⁺-calmodulin, participates in regulation of telomerase activity in Burkitt’s lymphoma cells

    • Rumiana Bakalova
    • Hideki Ohba
    • Yoshinobu Baba

    Original Article 23 April 2004 Pages: 161 - 172

    

11. Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

    • Toshiyuki Tsunoda
    • Tomonobu Koizumi
    • Keishi Kubo

    Original Article 04 May 2004 Pages: 173 - 177

    

12. Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer

    • G. Hütter
    • H. Szélenyi
    • E. Thiel

    Original Article 28 April 2004 Pages: 178 - 184

    

13. Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT₃ receptor antagonists in cancer patients

    • Yasuhiko Yamada
    • Munetoshi Sugiura
    • Tatsuji Iga

    Original Article 27 May 2004 Pages: 185 - 190

    

14. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer

    • Steven M. Sorscher

    Short Communication 18 May 2004 Pages: 191 - 192